Marc H. Scheetz
-
- Antibiotic Use and Resistance 46
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria 47
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 41
- Pharmacology top 0.2%
- Antibiotics Pharmacokinetics and Efficacy 102
- Infectious Diseases top 1%
- Antimicrobial Resistance in Staphylococcus 58
-
- Pneumonia and Respiratory Infections 30
- Sepsis Diagnosis and Treatment 19
-
- Acute Kidney Injury Research 18
- Co-authors
- Michael PostelnickNathaniel J. RhodesChao QiMichael MalczynskiMilena M. McLaughlinSean N. AvedissianGwendolyn PaisJiajun Liu
- Journals
- Antimicrobial Agents and Chemotherapy (42 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (15 papers)International Journal of Antimicrobial Agents (15 papers)
- Partner nations
- United StatesAustraliaGreece
In The Last Decade
Marc H. Scheetz
187 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 140
- Applied Microbiology and Biotechnology 788
- Molecular Medicine 1.3k
- Clinical Biochemistry 784
- Pharmacology 1.8k
- Infectious Diseases 1.4k
Countries citing papers authored by Marc H. Scheetz
This map shows the geographic impact of Marc H. Scheetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc H. Scheetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc H. Scheetz more than expected).
Fields of papers citing papers by Marc H. Scheetz
This network shows the impact of papers produced by Marc H. Scheetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc H. Scheetz. The network helps show where Marc H. Scheetz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marc H. Scheetz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 9 | |
| 8 | 2021 | 10 | |
| 9 | 2020 | 15 | |
| 10 | 2020 | 6 | |
| 11 | 2020 | 9 | |
| 12 | 2020 | 19 | |
| 13 | 2019 | 38 | |
| 14 | 2019 | 36 | |
| 15 | 2018 | 2 | |
| 16 | 2015 | 59 | |
| 17 | 2012 | 66 | |
| 18 | 2010 | 13 | |
| 19 | 2008 | 32 | |
| 20 | 2006 | 40 |
About Marc H. Scheetz
Marc H. Scheetz is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Clinical Biochemistry, having authored 199 papers that have together received 4.4k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (102 papers), Antimicrobial Resistance in Staphylococcus (58 papers), Antibiotic Resistance in Bacteria (47 papers), Antibiotic Use and Resistance (46 papers), Bacterial Identification and Susceptibility Testing (41 papers), Pneumonia and Respiratory Infections (30 papers), Sepsis Diagnosis and Treatment (19 papers) and Acute Kidney Injury Research (18 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (788 citations), Molecular Medicine (1.3k citations) and Clinical Biochemistry (784 citations). Marc H. Scheetz has collaborated with scholars based in United States, Australia and Greece. Frequent co-authors include Michael Postelnick, Nathaniel J. Rhodes, Chao Qi, Michael Malczynski, Milena M. McLaughlin, Sean N. Avedissian, Gwendolyn Pais, Jiajun Liu, Thomas P. Lodise and John S. Esterly. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, International Journal of Antimicrobial Agents, Journal of Antimicrobial Chemotherapy and Diagnostic Microbiology and Infectious Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.